AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan
AstraZeneca’s COVID-19 vaccine, Vaxzevria (ChAdOx1-S ), formerly AZD1222, has been granted a special approval for emergency use in Japan for active immunisation of individuals aged 18…
Read More...
Read More...
